Madrigal Pharmaceuticals's total assets for Q3 2025 were $1.36B, an increase of 34.18% from the previous quarter. GB:0JXI total liabilities were $345.32M for the fiscal quarter, a 8.11% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.